Loading
Mahkam Zanganeh received $1.2M in total compensation as Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc. in FY2024. The largest component was $600K in base salary. That’s down 94% from FY2023.
In fiscal year 2024, Mahkam Zanganeh, Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc. (SMMT), received total compensation of $1.2 million.
Mahkam Zanganeh's compensation breakdown includes: base salary of $600K, bonus of $540K, and other compensation of $21K.
Compared to fiscal year 2023, Mahkam Zanganeh's total compensation decreased 94% from $20.6 million to $1.2 million.
Summit Therapeutics Inc.'s top 4 named executive officers received combined total compensation of $6.3 million in fiscal year 2024.
The named executive officers disclosed in Summit Therapeutics Inc.'s 2024 proxy statement are:Mahkam Zanganeh (Co-Chief Executive Officer, President and Director) with total compensation of $1.2 million, Robert W. Duggan (Co-Chief Executive Officer and Chairman) with total compensation of $159K, Manmeet Soni (Chief Operating Officer, Chief Financial Officer and Director) with total compensation of $4.8 million, and Ankur Dhingra (Former Chief Financial Officer) with total compensation of $256K.
Source Filing
Executive Record
Mahkam Zanganeh
Co-Chief Executive Officer, President and Director
Reported Pay
$1.2M
Summary compensation table total · FY2024
Findings
Reviewing FY2024 compensation of $1.2M against +584% shareholder return and the latest filing-backed pay disclosures.
Reported pay changed -94%; spread versus stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for SMMT.
Team view
4 executives
Co-Chief Executive Officer, President and Director
Total PayFY2024
$1.2M
Co-Chief Executive Officer and Chairman
Total PayFY2024
$159K
Chief Operating Officer, Chief Financial Officer and Director
Total PayFY2024
$4.8M
Former Chief Financial Officer
Total PayFY2024
$256K
Ask a question about this filing
01FY2024 total compensation breakdown
$1.2M total compensation
Mahkam Zanganeh earned $1.2M in FY2024 — here's how that breaks down.
$600.0K
52% of total
$540.0K
47% of total
$21.0K
2% of total
Activity timeline · FY2024
Recent events from filings
Apr 2, 2024
Manmeet Soni Equity award (Exercise $1,100,000)
Jan 2, 2024
Robert W. Duggan Equity award (Exercise $74,545)
A pay-performance summary will appear here once the verdict loads above.
02Pay changes vs. stock performance
1 year of data
Peer context
Dashed line marks the large-cap median compensation benchmark for companies around $15.7B market cap, based on 312 peers in this size band.
03Recent insider trades by officers and directors
~32 trades
04Board composition and compensation for FY2026
This company is expected to file its proxy statement soon.
05Take action on executive compensation
Shareholder activism tools
Start or join campaigns to engage with SMMT's board on executive compensation, governance, and shareholder proposals.
Activism Beta — Sign in to start or join campaigns
06For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2024 | Mahkam Zanganeh Co-Chief Executive Officer, President and Director | $0.60M | $0.54M | $0.00M | $0.00M | $0.02M | $1.16M |
| 2023 | Mahkam Zanganeh Director, Chief Executive Officer, and President | $0.60M | $0.00M | $0.00M | $19.9M | $0.06M | $20.6M |
| 2022 | Mahkam Zanganeh Co-Chief Executive Officer, President and Director | $0.45M | $0.45M | $0.00M | $0.31M | $0.03M | $1.24M |
| 2021 | Mahkam Zanganeh Director, Chief Executive Officer, and President | $0.45M | $0.18M | $0.00M | $8.99M | $0.02M | $9.64M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.
Summit Therapeutics Inc. (SMMT) — Key Facts
Last updated Apr 5, 2026 · Source 20-F
| CEO | Mahkam Zanganeh, Co-Chief Executive Officer, President and Director |
|---|---|
| Fiscal year | FY2024 |
| Total compensation | $1.2M |
| Base salary | $600K |
| Other compensation | $21K |
| Year-over-year change | -94% |
| Source | 20-F |
Mahkam Zanganeh, the Co-Chief Executive Officer, President and Director of Summit Therapeutics Inc., received total compensation of $1.2 million in fiscal year 2024. This includes base salary of $600,000.
Mahkam Zanganeh's base salary at Summit Therapeutics Inc. is $600,000 per year as of fiscal year 2024. However, total compensation including stock awards, bonuses, and other benefits is $1.2 million.
Summit Therapeutics Inc.'s CEO, Mahkam Zanganeh, earned $1.2 million in total compensation for fiscal year 2024.